Buchang Group
Buchang Pharma (????) provides pharmaceutical products, research, and sales in China.
Launch date
Employees
Market cap
$2.2b
Enterprise valuation
$2.6b (Public information from Sep 2024)
Share price
CNY15.08 603858.SS
Xi'an Shaanxi (HQ)
Financials
Estimates*
| CNY | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Revenues | 14.3b | 16.0b | 15.8b | 15.0b | 13.2b |
| % growth | - | 12 % | (2 %) | (5 %) | (11 %) |
| EBITDA | 2.9b | 2.9b | 2.5b | 2.4b | 1.8b |
| % EBITDA margin | 20 % | 18 % | 16 % | 16 % | 14 % |
| Profit | 1.9b | 1.9b | 1.3b | (1.7b) | 319m |
| % profit margin | 14 % | 12 % | 8 % | (11 %) | 2 % |
| R&D budget | 505m | 533m | 409m | 284m | 335m |
| R&D % of revenue | 4 % | 3 % | 3 % | 2 % | 3 % |
| Date | Investors | Amount | Round |
|---|---|---|---|
N/A | Seed | ||
| N/A | N/A | IPO | |
| N/A | N/A | IPO | |
| Total Funding | - | ||
